Zacks: Analysts Expect Xylem Inc. (XYL) Will Post Quarterly Sales of $1.17 Billion

Brokerages expect Xylem Inc. (NYSE:XYL) to announce $1.17 billion in sales for the current quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Xylem’s earnings, with estimates ranging from $1.16 billion to $1.19 billion. Xylem posted sales of $932.00 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 25.5%. The company is expected to issue its next earnings report before the market opens on Tuesday, August 1st.

On average, analysts expect that Xylem will report full-year sales of $1.17 billion for the current fiscal year, with estimates ranging from $4.53 billion to $4.76 billion. For the next fiscal year, analysts expect that the company will report sales of $4.81 billion per share, with estimates ranging from $4.78 billion to $4.86 billion. Zacks’ sales calculations are an average based on a survey of sell-side research analysts that follow Xylem.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Tuesday, May 2nd. The industrial products company reported $0.39 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.38 by $0.01. The firm had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Xylem had a return on equity of 15.53% and a net margin of 6.75%. The company’s quarterly revenue was up 26.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.35 EPS.

A number of equities analysts have recently issued reports on the company. Stifel Nicolaus restated a “hold” rating and set a $60.00 price objective on shares of Xylem in a research report on Friday, July 14th. Oppenheimer Holdings, Inc. raised their price objective on Xylem from $58.00 to $60.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 12th. Zacks Investment Research upgraded Xylem from a “hold” rating to a “buy” rating and set a $62.00 price objective for the company in a research report on Tuesday, July 4th. BidaskClub upgraded Xylem from a “hold” rating to a “buy” rating in a research report on Wednesday, June 28th. Finally, BMO Capital Markets assumed coverage on Xylem in a research report on Wednesday, June 21st. They set an “outperform” rating and a $60.00 price objective for the company. Four investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $56.85.

ILLEGAL ACTIVITY WARNING: This article was first published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this article on another site, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this article can be viewed at https://www.com-unik.info/2017/07/26/zacks-analysts-expect-xylem-inc-xyl-will-post-quarterly-sales-of-1-17-billion.html.

In other Xylem news, insider Tomas Brannemo sold 14,080 shares of the firm’s stock in a transaction that occurred on Thursday, May 4th. The stock was sold at an average price of $50.36, for a total value of $709,068.80. Following the completion of the sale, the insider now owns 21,000 shares of the company’s stock, valued at $1,057,560. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Steven R. Loranger sold 66,132 shares of the firm’s stock in a transaction that occurred on Thursday, June 29th. The shares were sold at an average price of $55.01, for a total value of $3,637,921.32. Following the completion of the sale, the director now directly owns 65,030 shares of the company’s stock, valued at approximately $3,577,300.30. The disclosure for this sale can be found here. Company insiders own 0.75% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its position in shares of Xylem by 3.7% in the first quarter. Vanguard Group Inc. now owns 17,287,871 shares of the industrial products company’s stock valued at $868,197,000 after buying an additional 619,368 shares during the last quarter. BlackRock Inc. boosted its position in shares of Xylem by 2,452.8% in the first quarter. BlackRock Inc. now owns 12,042,342 shares of the industrial products company’s stock valued at $604,765,000 after buying an additional 11,570,613 shares during the last quarter. Pictet Asset Management Ltd. boosted its position in shares of Xylem by 34.3% in the first quarter. Pictet Asset Management Ltd. now owns 4,024,188 shares of the industrial products company’s stock valued at $202,095,000 after buying an additional 1,027,438 shares during the last quarter. Janus Capital Management LLC boosted its position in shares of Xylem by 3.5% in the first quarter. Janus Capital Management LLC now owns 2,563,661 shares of the industrial products company’s stock valued at $128,747,000 after buying an additional 86,938 shares during the last quarter. Finally, Impax Asset Management LTD boosted its position in shares of Xylem by 24.5% in the first quarter. Impax Asset Management LTD now owns 2,404,602 shares of the industrial products company’s stock valued at $120,758,000 after buying an additional 472,504 shares during the last quarter. 85.91% of the stock is currently owned by institutional investors.

Shares of Xylem (NYSE XYL) traded down 0.19% during mid-day trading on Wednesday, reaching $57.10. The company’s stock had a trading volume of 336,117 shares. The company has a 50-day moving average of $54.83 and a 200-day moving average of $51.03. The firm has a market cap of $10.26 billion, a PE ratio of 41.08 and a beta of 1.18. Xylem has a 12 month low of $45.60 and a 12 month high of $57.85.

About Xylem

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Get a free copy of the Zacks research report on Xylem (XYL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Xylem (NYSE:XYL)

What are top analysts saying about Xylem Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Xylem Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit